These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 4833680

  • 1. [Effect of neuroleptics on the content of dopamine and DOPAC in the caudate nucleus of the rat].
    Gérardy J, Dresse A.
    Experientia; 1974 May 15; 30(5):523-4. PubMed ID: 4833680
    [No Abstract] [Full Text] [Related]

  • 2. [Action of three neuroleptics on the DOPAC level in the caudate nucleus of the rat].
    Gerardy J, Cajgfinger G.
    Arch Int Pharmacodyn Ther; 1972 Sep 15; 199(1):197-200. PubMed ID: 5072188
    [No Abstract] [Full Text] [Related]

  • 3. The dopamine-releasing actions of neuroleptics and ethanol.
    Seeman P, Lee T.
    J Pharmacol Exp Ther; 1974 Jul 15; 190(1):131-40. PubMed ID: 4847309
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR, Grant LD, Breese GR.
    Psychopharmacologia; 1973 Jul 17; 31(2):95-109. PubMed ID: 4722209
    [No Abstract] [Full Text] [Related]

  • 5. Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.
    Argiolas A, Paglietti E, Fadda F, Quarantotti BP, Gessa GL.
    Life Sci; 1978 Feb 17; 22(6):461-6. PubMed ID: 625191
    [No Abstract] [Full Text] [Related]

  • 6. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
    Fadda F, Argiolas A, Stefanini E, Gessa GL.
    Life Sci; 1977 Aug 01; 21(3):411-7. PubMed ID: 895373
    [No Abstract] [Full Text] [Related]

  • 7. Histological and molecular biochemistry.
    Andén NE, Bartholini G, Corrodi H, Csillik B, De Robertis E, Dresse A, Fuxe K, Gerebtzoff MA, Glowinski J, Hansson E, Hökfelt T, Renson J, Roos BE.
    Mod Probl Pharmacopsychiatry; 1970 Aug 01; 5():1-11. PubMed ID: 4348145
    [No Abstract] [Full Text] [Related]

  • 8. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus.
    McKenzie GM, Szerb JC.
    J Pharmacol Exp Ther; 1968 Aug 01; 162(2):302-8. PubMed ID: 4385909
    [No Abstract] [Full Text] [Related]

  • 9. [Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
    Stille G.
    Schweiz Med Wochenschr; 1969 Nov 15; 99(46):1645-52 contd. PubMed ID: 4391348
    [No Abstract] [Full Text] [Related]

  • 10. Reserpine-like action of chlorpromazine on rabbit basal ganglia.
    Tagliamonte A, Tagliamonte P, Gessa GL.
    J Neurochem; 1970 Jun 15; 17(6):733-8. PubMed ID: 5426652
    [No Abstract] [Full Text] [Related]

  • 11. Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain.
    Rollema H, Westerink BH, Grol CJ.
    J Pharm Pharmacol; 1976 Apr 15; 28(4):321-3. PubMed ID: 6728
    [No Abstract] [Full Text] [Related]

  • 12. [Compared potentiating effect caused by different neuroleptics opposite of the action of several hypnotics in the mouse].
    Boismare F, Streichenberger G, Lechat P.
    Therapie; 1967 Apr 15; 22(6):1317-24. PubMed ID: 5590797
    [No Abstract] [Full Text] [Related]

  • 13. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB.
    Farmakol Toksikol; 1973 Apr 15; 26(4):481-9. PubMed ID: 4151298
    [No Abstract] [Full Text] [Related]

  • 14. Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs.
    Keller HH, Bartholini G, Pletscher A.
    Eur J Pharmacol; 1973 Aug 15; 23(2):183-6. PubMed ID: 4733777
    [No Abstract] [Full Text] [Related]

  • 15. [Dopamine metabolism in the rabbit caudate nucleus following partial inhibition of brain monoamine oxidase by nialamide].
    Lisch HJ, Aigner A, Hornykiewicz O.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 Aug 15; 261(4):289-98. PubMed ID: 4235430
    [No Abstract] [Full Text] [Related]

  • 16. Effect of decarboxylase inhibition and neuroleptic drugs on the DOPA level in rat brain.
    Cegrell L, Nordgren L, Rosengren AM.
    Res Commun Chem Pathol Pharmacol; 1970 Jul 15; 1(4):479-84. PubMed ID: 4400174
    [No Abstract] [Full Text] [Related]

  • 17. Effect of drugs used in psychoses on cerebral dopamine metabolism.
    O'Keeffe R, Sharman DF, Vogt M.
    Br J Pharmacol; 1970 Feb 15; 38(2):287-304. PubMed ID: 4984801
    [Abstract] [Full Text] [Related]

  • 18. [Cellular effect of neuroleptics].
    Kuschinsky K.
    Dtsch Med Wochenschr; 1975 Jun 20; 100(25):1405-8. PubMed ID: 237751
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.